XML 63 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value FAIR VALUE
Fair Value Measurement
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. For a discussion of the Bank’s valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 3 of our 2018 Annual Report on Form 10-K.
Quantitative Disclosure by Fair Value Hierarchy
Assets and liabilities measured at fair value by class on a recurring basis are summarized as follows:
(In millions)September 30, 2019
Level 1Level 2Level 3Total
ASSETS
Investment securities:
Available-for-sale: 1
U.S. Treasury, agencies and corporations$25  $12,639  $—  $12,664  
Municipal securities1,344  1,344  
Other debt securities25  25  
Total Available-for-sale25  14,008  —  14,033  
Trading account127  153  280  
Other noninterest-bearing investments:
Bank-owned life insurance525  525  
Private equity investments108  108  
Other assets:
Agriculture loan servicing and interest-only strips19  19  
Deferred compensation plan assets108  108  
Derivatives:
Derivatives not designated as hedges:
Customer-facing interest rate203  203  
Other interest rate  
Foreign exchange  
Total Assets$263  $14,893  $127  $15,283  
LIABILITIES
Securities sold, not yet purchased$ $—  $—  $ 
Other liabilities:
Deferred compensation plan obligations108  108  
Derivatives:
Derivatives not designated as hedges:
Customer-facing interest rate13  13  
Other interest rate  
Foreign exchange  
Total Liabilities$114  $14  $—  $128  
1 We used a third-party pricing service to measure fair value for approximately 94% of our AFS Level 2 securities.
(In millions)December 31, 2018
Level 1Level 2Level 3Total
ASSETS
Investment securities:
Available-for-sale: 1
U.S. Treasury, agencies and corporations$40  $13,385  $—  $13,425  
Municipal securities1,291  1,291  
Other debt securities21  21  
Total Available-for-sale40  14,697  —  14,737  
Trading account14  92  106  
Other noninterest-bearing investments:
Bank-owned life insurance516  516  
Private equity investments102  102  
Other assets:
Agriculture loan servicing and interest-only strips18  18  
Deferred compensation plan assets95  95  
Derivatives:
Derivatives not designated as hedges:
Customer-facing interest rate40  40  
Other interest rate  
Foreign exchange  
Total Assets$153  $15,346  $120  $15,619  
LIABILITIES
Securities sold, not yet purchased$85  $—  $—  $85  
Other liabilities:
Deferred compensation plan obligations95  95  
Derivatives:
Derivatives not designated as hedges:
Customer-facing interest rate36  36  
Other interest rate  
Foreign exchange  
Total Liabilities$182  $37  $—  $219  
1 We used a third-party pricing service to measure fair value for approximately 95% of our AFS Level 2 securities.
Level 3 Valuations
The Bank’s Level 3 holdings include private equity investments (“PEIs”), agriculture loan servicing, and interest-only strips. For additional information regarding the financial instruments measured under Level 3, and the methods and significant assumptions used to estimate their fair value, see Note 3 of our 2018 Annual Report on Form 10-K.
Reconciliation of Level 3 Fair Value Measurements
The following reconciles the beginning and ending balances of assets and liabilities that are measured at fair value by class on a recurring basis using Level 3 inputs:
Level 3 Instruments
Three Months EndedNine Months Ended
September 30, 2019September 30, 2018September 30, 2019September 30, 2018
(In millions)Private
equity
investments
Ag loan svcg and int-only stripsPrivate
equity
investments
Ag loan svcg and int-only stripsPrivate equity investmentsAg loan svcg and int-only stripsPrivate equity investmentsAg loan svcg and int-only strips
Balance at beginning of period
$105  $19  $102  $18  $102  $18  $95  $18  
Securities gains (losses), net
 —  (1) —  —  —  —  —  
Other noninterest income
—  —  —  —  —   —  —  
Purchases —   —   —   —  
Balance at end of period
$107  $19  $103  $18  $107  $19  $103  $18  
The reconciliation of Level 3 instruments includes $9 million in realized losses in the statement of income during the three months ended September 30, 2019, and no realized gains and losses during the same period in 2018. During the nine months ended September 30, there was $9 million in realized losses in the statement of income in 2019 and $3 million in realized losses in 2018.
Nonrecurring Fair Value Measurements
Included in the balance sheet amounts are the following amounts of assets that had fair value changes measured on a nonrecurring basis.
(In millions)Fair value at September 30, 2019Fair value at December 31, 2018  
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
ASSETS
Private equity investments$—  $—  $ $ $—  $—  $ $ 
Impaired loans—   —   —  32  —  32  
Other real estate owned—   —   —  —  —  —  
Total$—  $ $ $ $—  $32  $ $33  
The previous fair values may not be current as of the dates indicated, but rather as of the date the fair value change occurred, such as a charge for impairment. Accordingly, carrying values may not equal current fair value.
Gains (losses) from fair value changes
(In millions)Three Months Ended
September 30,
Nine Months Ended
September 30,
2019201820192018
ASSETS
Private equity investments$(1) $—  $(1) $—  
Impaired loans—  (9) (9) (15) 
Other real estate owned—  —  (1) (1) 
Total$(1) $(9) $(11) $(16) 
During the three months ended September 30, we recognized $2 million of net gains in 2019 and an insignificant amount of net gains in 2018 from the sale of other real estate owned (“OREO”) properties. During the nine months ended September 30, we recognized $3 million of net gains in 2019 and $1 million in 2018 from the sale of OREO properties that had a carrying value, at the time of sale, of $4 million and $3 million during these same periods. Prior to their sale, we recognized an insignificant amount of impairment on these properties during the nine months ended September 30, 2019 and 2018.
Private equity investments carried at cost were measured at fair value for impairment purposes according to the methodology previously discussed for these investments. Amounts of PEIs carried at cost were $8 million at
September 30, 2019 and $10 million at December 31, 2018. Amounts of other noninterest-bearing investments carried at cost were $252 million at September 30, 2019 and $329 million at December 31, 2018, which were comprised of Federal Reserve and Federal Home Loan Bank (“FHLB”) stock. Private equity investments accounted for using the equity method were $41 million at September 30, 2019 and $35 million at December 31, 2018.
Impaired (or nonperforming) loans that are collateral-dependent were measured at fair value based on the fair value of the collateral. OREO was measured initially at fair value based on collateral appraisals at the time of transfer and subsequently at the lower of cost or fair value. For additional information regarding the measurement of fair value for impaired loans, collateral-dependent loans, and OREO, see Note 3 of our 2018 Annual Report on Form 10-K.
Fair Value of Certain Financial Instruments
Following is a summary of the carrying values and estimated fair values of certain financial instruments:
 September 30, 2019December 31, 2018
(In millions)Carrying
value
Estimated
fair value
LevelCarrying
value
Estimated
fair value
Level
Financial assets:
HTM investment securities$658  $662  2$774  $767   
Loans and leases (including loans held for sale), net of allowance
48,466  47,819  346,312  45,251   
Financial liabilities:
Time deposits4,942  4,953  24,336  4,319   
Long-term debt1,242  1,255  2724  727   
This summary excludes financial assets and liabilities for which carrying value approximates fair value and financial instruments that are recorded at fair value on a recurring basis. For additional information regarding the financial instruments within the scope of this disclosure, and the methods and significant assumptions used to estimate their fair value, see Note 3 of our 2018 Annual Report on Form 10-K.